Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Walker

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Brain Research|September 15, 2004
Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the ratChristopher Bishop, Paul D Walker
Synapse (New York, N.Y.)|May 20, 2004
NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulationChristian W Kreipke, Paul D Walker
Neuroreport|April 2, 2002
Striatal tachykinin and enkephalin mRNAs are normalized by serotonin2 and NMDA manipulation following dopamine depletionBrian M Campbell, Paul D Walker
Plos One|August 23, 2013
A Tet-on system for DRD1-expressing cellsFayi Yao, Paul D Walker, Robert G MacKenzie
Scientific Reports|April 29, 2020
Greyhound racing ideal trajectory path generation for straight to bend based on jerk rate minimizationMd Imam Hossain, David Eager, Paul D Walker
Synapse (New York, N.Y.)|August 19, 2003
Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned ratsChristopher Bishop, Dev P Kamdar, Paul D Walker
Synapse (New York, N.Y.)|April 29, 2005
Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonismDavid M Krolewski, Christopher Bishop, Paul D Walker
Neuropharmacology|July 5, 2005
Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958Christopher Bishop, Gregory S Daut, Paul D Walker
Pharmacology, Biochemistry, and Behavior|July 19, 2005
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted ratJennifer L Taylor, Christopher Bishop, Paul D Walker
Pharmacotherapy|December 26, 2003
Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a reviewPaul D Walker, Kristi L Brokering, John C Theobald
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Brain Research|September 15, 2004
Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the ratChristopher Bishop, Paul D Walker
Synapse (New York, N.Y.)|May 20, 2004
NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulationChristian W Kreipke, Paul D Walker
Neuroreport|April 2, 2002
Striatal tachykinin and enkephalin mRNAs are normalized by serotonin2 and NMDA manipulation following dopamine depletionBrian M Campbell, Paul D Walker
Plos One|August 23, 2013
A Tet-on system for DRD1-expressing cellsFayi Yao, Paul D Walker, Robert G MacKenzie
Scientific Reports|April 29, 2020
Greyhound racing ideal trajectory path generation for straight to bend based on jerk rate minimizationMd Imam Hossain, David Eager, Paul D Walker
Synapse (New York, N.Y.)|August 19, 2003
Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned ratsChristopher Bishop, Dev P Kamdar, Paul D Walker
Synapse (New York, N.Y.)|April 29, 2005
Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonismDavid M Krolewski, Christopher Bishop, Paul D Walker
Neuropharmacology|July 5, 2005
Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958Christopher Bishop, Gregory S Daut, Paul D Walker
Pharmacology, Biochemistry, and Behavior|July 19, 2005
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted ratJennifer L Taylor, Christopher Bishop, Paul D Walker
Pharmacotherapy|December 26, 2003
Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a reviewPaul D Walker, Kristi L Brokering, John C Theobald
Pageof 4